Blockchain Registration Transaction Record

AFib Patient Finds Freedom with Medtronic LINQ II and Ablation

Todd Repass Jr. shares his AFib journey with Medtronic's LINQ II insertable cardiac monitor and Affera ablation system, offering hope for better arrhythmia management.

Atrial fibrillation affects over 10 million U.S. adults, yet many struggle to get an accurate diagnosis because episodes are unpredictable and often missed by short-term monitors. Todd Repass Jr.’s story highlights how long-term continuous monitoring with insertable cardiac monitors like the Medtronic LINQ II can capture critical data, leading to more targeted treatments such as pulsed field ablation. For patients, this means fewer unanswered questions, less anxiety, and better outcomes. It also underscores the vital role of caregiver support and informed decision-making. As AFib prevalence grows with an aging population, innovations in monitoring and ablation offer hope for improved quality of life and reduced risk of stroke and heart failure.